AppySleep (OTCQB: APYP)

SleepX Ltd. (OTCQB: APYP) is a digital health company focused on developing accurate wearable monitoring solutions to treat sleep apnea and snoring. Its flagship solution, AppySleep, is a patented wristband that communicates with a smartphone app to gently vibrate with every breathing interruption, training the brain to breathe properly. The company's machine learning technology adapts the treatment and recommends improvements based on the user's sleep and breathing patterns. Additionally, AppySleep tracks sleep patterns and provides important statistics to track and detect anomalies over time. Collaborating with the Biomedical department of the Ben Gurion University of the Negev, the product is patent-protected in the US, EU, and Israel. With the global anti-snoring treatment market expected to grow to USD 8.6 billion by 2028 and the global sleep apnea devices market predicted to reach USD 6.1 billion by 2028, SleepX operates in a promising market. Founded in 2019, SleepX is headquartered in 447 Broadway 2nd FL, New York, NY 10013.